EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 319 (2021) E3S Web Conf., 319 (2021) 01048 References
Open Access
Issue
E3S Web Conf.
Volume 319, 2021
International Congress on Health Vigilance (VIGISAN 2021)
Article Number 01048
Number of page(s) 7
DOI https://doi.org/10.1051/e3sconf/202131901048
Published online 09 November 2021
  1. Centers of Disease Control and Prevention. Antibiotic resistance threats in the United States. U.S. department of health and human services, United States. [2013] ; pp : 31–57. [Google Scholar]
  2. Schlemmer B. Régulation de l’utilisation des antibiotiques : objectifs, moyens et perspectives Éditions scientifiques et médicales Elsevier SAS. Annales Françaises d’Anesthésie et de Réanimation. Vol.19, Issue 5, [May 2000], 403-408. [CrossRef] [Google Scholar]
  3. Young-MinYe MD, PhD, Seung-KwanLim MD, Young-Wha Choi MD, PhD, So-Hee Lee MD, Ji-Ho Lee MD, Seung-Hee Park, Lee Young-Hee. Adverse drug reactions to antibiotics collected by a pharmacovigilance center in Korea: an eightyear retrospective study. Journal of Allergy and Clinical Immunology, suppl. S; St. Louis Vol. 141, N° 2, (Feb 1, [2018]: AB87. [Google Scholar]
  4. Rouveix B. Antibiotic safety assessment. Int J Antimicrob Agent [2003];21:215-21. [CrossRef] [Google Scholar]
  5. Duong.K. Evaluation de l’évitabilité des effets indésirables médicamenteux à partir des bases de données de pharmacovigilance de bordeaux et du vietnam (PREVENT –ASRs), Pharmacovigilance, Bordeaux ,Université de Bordeaux [2017] ,70 [Google Scholar]
  6. E. Polard , La pharmacovigilance des antibiotiques Exemples de quelques effets indésirables rapportés avec les bêtalactamines, les fluoroquinolones, les macrolides et les cyclines, La Lettre de l’Infectiologue - Tome XX - n° 6 - [novembre-décembre 2005]. [Google Scholar]
  7. Lefébre L, Mathieu M, Nantel A, Rambourg SM. Définitions INTOX. [Mars2000] [Google Scholar]
  8. Donner. A, Banting. D. Adjustment of Frequently Used Chi-square Procedures for the Effect of Site-to-Site Dependencies in the Analysis of Dental Data. J Dent Res [1989] 68(9):1350-1354. [Google Scholar]
  9. Curtin F., Schulz P. Assessing the benefit: risk ratio of a drug—randomized and naturalistic evidence. Dialog Clin Neurosci. [2011];13(2):183-90. [CrossRef] [Google Scholar]
  10. World Health Organization, UMC Glossary Disponible on https://www.who-umc.org/global-pharmacovigilance/global-pharmacovigilance/glossary/ [Consulted on 09/06/2018]. [Google Scholar]
  11. Montastruc J- L, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, … et Bagheri H[2006].. La pharmacovigilance et l’évaluation du risque médicamenteux: intérêt, fonctionnement et méthodes. Revue du rhumatisme vol. 73, no 10, p. 1021-1024., [2006]. [CrossRef] [Google Scholar]
  12. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in LagosNigeria. BMC Clin Pharmacol [2009] 9: 14.. [CrossRef] [PubMed] [Google Scholar]
  13. World Health Organization Programme Members. Countries participating in the WHO Programme for International Drug Monitoring, with year of joining. Disponible on http://www.who-umc.org/DynPage.aspx?id=100653&mn1=7347&mn2=7252&mn3=7322&mn4=442 [Consulted on 09/06/2018] [Google Scholar]
  14. Oshikoya KA. Treating children for malaria fever in theface of counterfeit and fake medicines. Int J Med Med Sci [2010]. 2:1–2. [Google Scholar]
  15. NAFDAC. National Agency for Food and Drug Administration and Control NAFDAC Act.2016]. Disponible on http://www.nafdac.gov.ng/index.php/about-nafdac/nafdac-act. [Consulted on 02/03/2018 ]. [Google Scholar]
  16. Olivier P, Boulbés O,Tubery M, Lauque D, Montastruc JL, Lapeyre Mestre M, Assessing the Feasibility of Using an Adverse Drug Reaction Preventability Scale in Clinical Practice. Drug Saf[2002] ;25:1035-44 [CrossRef] [PubMed] [Google Scholar]
  17. Rademaker, M., Do women have more adverse drug reactions? Am J Clin Dermatol [2001]; 2 (6): 349-51. [CrossRef] [PubMed] [Google Scholar]
  18. Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women, United States General Accounting Office Washington, DC, GAO 01-286R. [Google Scholar]
  19. Richa Tandon V R, Sharma S, Khajuria V, Mahajan V, Gillani Z. Adverse drug reactions profile of antimicrobials: a 3-year experience, from a tertiary care teaching hospital of India. Indian J Med Microbiol [2015] 33: 393–400 [CrossRef] [PubMed] [Google Scholar]
  20. Doan Tp, Tran T, Vu D, Nguyen H ; Identification of preventable adverse drug reaction on the Vietnamese Pharmacovogolance Database : A retrospective Analysis .Bangkok , Thailand : The first international conference on pharmacy education and reseach Network of ASEAN (ASEAN PharmNET I) ; [2015] déc. [Consulted on 02/04/2018 http://canhgiacduoc.org.vn/SiteData/3/UserFiles/Poster%20Thao%20(1).pdf] [Google Scholar]
  21. Bandekar MS, Anwikar SR, Kshirsagar NA. Quality check of spontaneous adverse drug reaction reporting forms of different countries, phamacoepidemiol Drug Saf [2010] ; 19;1181-5 [CrossRef] [Google Scholar]
  22. Van Duong D, Binns CW, Van Le T Availability of antibiotics as over the counter drugs in pharmacies : a threat to public health in Vietnam.Trop Med Int Health TM IH [1997];2;1133-9 [CrossRef] [PubMed] [Google Scholar]
  23. El Yallouli El Idrissi, Elmehdi. La pratique de l’automédication : enquête dans la ville de Fès au Maroc. Thése de pharmacie, Rabat ,Université mohamed V [2016];,125 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.